TickerFacts.

A business in context

AMLX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-416950

  2. 4 · Ownership change

    Report date 2026-09-10 · 0001193125-26-390510

  3. 4 · Ownership change

    Report date 2026-09-10 · 0001193125-26-390509

  4. 4 · Ownership change

    Report date 2026-09-10 · 0001193125-26-390508

  5. 4 · Ownership change

    Report date 2026-09-10 · 0001193125-26-390507

  6. 4 · Ownership change

    Report date 2026-09-10 · 0001193125-26-390506

  7. 8-K · Current report

    Report date 2026-09-01 · 0001193125-26-385331 · Items 1.01

  8. 4 · Ownership change

    Report date 2026-08-31 · 0001193125-26-380152

  9. 4 · Ownership change

    Report date 2026-08-18 · 0001193125-26-359679

  10. 8-K · Current report

    Report date 2026-08-19 · 0001193125-26-359418 · Items 1.01,9.01

  11. 8-K · Current report

    Report date 2026-08-18 · 0001193125-26-354793 · Items 8.01,9.01

  12. 8-K · Current report

    Report date 2026-08-18 · 0001193125-26-354716 · Items 7.01,8.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-336682

  14. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-336670 · Items 2.02,9.01

  15. 8-K · Current report

    Report date 2026-06-04 · 0001193125-26-257390 · Items 5.07

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-210292

  17. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-210286 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-06-04 · 0001193125-26-171800

  19. 8-K · Current report

    Report date 2026-03-24 · 0001193125-26-120691 · Items 7.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-086645

  21. 8-K · Current report

    Report date 2026-03-03 · 0001193125-26-086629 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-01-08 · 0001193125-26-006991 · Items 7.01,8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-268059

  24. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-268043 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-09-09 · 0001193125-25-200159 · Items 1.01,9.01

  26. 8-K · Current report

    Report date 2025-08-27 · 0001193125-25-189109 · Items 8.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-174948

  28. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-104546 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-06-05 · 0001193125-25-135860 · Items 5.07

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066363

  31. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066355 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0000950170-25-057665

  33. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-031309

  34. 8-K · Current report

    Report date 2025-03-04 · 0000950170-25-031303 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-01-10 · 0001193125-25-004547 · Items 1.01,9.01

  36. 8-K · Current report

    Report date 2024-12-30 · 0001193125-24-286212 · Items 7.01

  37. SC 13G/A · Ownership disclosure

    0000932471-24-000840

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122833

  39. 8-K · Current report

    Report date 2024-11-07 · 0000950170-24-122779 · Items 2.02,9.01

  40. SC 13G · Ownership disclosure

    0000932471-24-000246

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 12 transaction rows12SGrant / award: 5 transaction rows5AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

21 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-10
2026-09-14
Bedrosian Camille LS · Sale
Disposed
Common Stock7947.032.21
2026-09-10
2026-09-14
Bedrosian Camille LS · Sale
Disposed
Common Stock2081.033.09
2026-09-10
2026-09-14
FRATES JAMES MS · Sale
Disposed
Common Stock9768.032.27
2026-09-10
2026-09-14
FRATES JAMES MS · Sale
Disposed
Common Stock1042.033.23
2026-09-10
2026-09-14
Mazzariello GinaS · Sale
Disposed
Common Stock9525.032.46
2026-09-10
2026-09-14
Mazzariello GinaS · Sale
Disposed
Common Stock11.033.34
2026-09-10
2026-09-14
Cohen Joshua BS · Sale
Disposed
Common Stock919.033.15
2026-09-10
2026-09-14
Cohen Joshua BS · Sale
Disposed
Common Stock29545.032.16
2026-09-10
2026-09-14
Klee Justin B.S · Sale
Disposed
Common Stock1439.033.16
2026-09-10
2026-09-14
Klee Justin B.S · Sale
Disposed
Common Stock29025.032.13
2026-08-31
2026-09-02
Firestone KarenM · Exercise / conversion
Acquired
Common Stock25000.01.76
2026-08-31
2026-09-02
Firestone KarenM · Exercise / conversion
Acquired
Common Stock25000.05.05
2026-08-31
2026-09-02
Firestone KarenM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
25000.00.0
2026-08-31
2026-09-02
Firestone KarenM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
25000.00.0
2026-08-18
2026-08-20
FRATES JAMES MA · Grant / award
Acquired
Common Stock22807.00.0
2026-08-18
2026-08-20
Klee Justin B.A · Grant / award
Acquired
Common Stock60039.00.0
2026-08-18
2026-08-20
Mazzariello GinaA · Grant / award
Acquired
Common Stock21284.00.0
2026-08-18
2026-08-20
Bedrosian Camille LA · Grant / award
Acquired
Common Stock22807.00.0
2026-08-18
2026-08-20
Cohen Joshua BA · Grant / award
Acquired
Common Stock60039.00.0
2026-07-10
2026-07-13
Mazzariello GinaS · Sale
Disposed
Common Stock15000.017.61
2026-07-09
2026-07-13
Mazzariello GinaS · Sale
Disposed
Common Stock15000.018.32

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001658551Amylyx Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$87.37M$93.84M
    2023-12-31$380.79M$421.05M
    2022-12-31$22.23M$25.59M
    2021-12-31$285.0K$354.3K

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗